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Abstract
Sox3/SOX3 is one of the earliest neural markers in vertebrates. Together with the Sox1/
SOX1 and Sox2/SOX2 genes it is implicated in the regulation of stem cell identity. In the
present study, we performed the first analysis of epigenetic mechanisms (DNAmethylation
and histone marks) involved in the regulation of the human SOX3 gene expression during
RA-induced neural differentiation of NT2/D1 cells. We show that the promoter of the human
SOX3 gene is extremely hypomethylated both in undifferentiated NT2/D1 cells and during
the early phases of RA-induced neural differentiation. By employing chromatin immunopre-
cipitation, we analyze several histone modifications across different regions of the SOX3
gene and their dynamics following initiation of differentiation. In the same timeframe we
investigate profiles of selected histone marks on the promoters of human SOX1 and SOX2
genes. We demonstrate differences in histone signatures of SOX1, SOX2 and SOX3
genes. Considering the importance of SOXB1 genes in the process of neural differentiation,
the present study contributes to a better understanding of epigenetic mechanisms impli-
cated in the regulation of pluripotencymaintenance and commitment towards the neural
lineage.
Introduction
SOX3/Sox3 is an X-linked member of SOXB1 (SOX1-3) subfamily of transcriptional regulators
[1–3]. Together with SOX1 and SOX2 it is expressed in neural progenitors where they counter-
act the activity of proneural proteins and maintain undifferentiated state of progenitor cells
[4]. SOX2 gene, the closest relative of SOX3, is one of the core pluripotency factors involved in
the regulation of stemness and differentiation [3,5,6]. SOX3 is recognized as one of the earliest
neural markers in vertebrates; up to date the role of Sox3 in neural development has been the
most studied aspect of the Sox3 action.
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It was shown that in murine telencephalon Sox3 is expressed in neural stem/progenitor
cells (NP cells) during embryonic development and it is downregulated during neuronal dif-
ferentiation [7]. In adult mice telencephalon, Sox3 expression is maintained only in progenitor
cells of the adult neurogenic regions, subventricular and subgranular zones [7]. In contrast,
during hypothalamic neurogenesis Sox3 expression is not restricted to neural progenitors, but
to developing neurons and is maintained in a subset of differentiated hypothalamic cells
through adulthood [7]. Consistent with its expression patterns, Sox3 plays important roles in
the process of neural differentiation, as confirmed by genome-wide binding studies that veri-
fied its status as one of the earliest markers of vertebrate neurogenesis. It has been demon-
strated that in mouse ES-derived NP cells Sox3 target genes have regulatory roles during
development of the CNS [1]. While Sox3 mainly activates genes expressed in NP cells, it also
binds to neuronal genes, preventing premature Sox11 binding and their consequent activation
[1]. Recent studies have identified Sox3 target sites in murine NP cells in putative enhancers of
neurodevelopmental genes, located primarily within the intergenic regions [8]. Furthermore,
Sox3 acts as a pioneer factor whose binding to target enhancers establishes local epigenetic
changes [1]. Due to functional redundancy between SoxB1 genes the expression of most NP
genes is not affected in Sox3 null NP cells. Nevertheless, direct Sox3 targets have been identi-
fied with expression not rescued by other SoxB1 members [9].
Besides the prominent roles in the process of neural differentiation, there is evidence point-
ing at SOX3 as one of the players in the maintenance of human embryonal stem cells (hESCs)
identity. Together with SOX2, SOX3 is implicated in the regulation of self-renewal and pluri-
potency of hESCs [10]. SOX3 is upregulated after the knockdown of SOX2 in hESC, keeping
the cells in an undifferentiated state, while the self-renewal ability is reduced under these con-
ditions [10]. Moreover, it was established that Sox1 and Sox3 can replace Sox2 during the pro-
cess of iPSCs (induced pluripotent stem cells) generation from mouse embryonic fibroblasts
(mEFs) [11]. Taken together, these data highlight the role of Sox3 in the selection and proper
execution of developmental programs established through complex coordination between
Sox3 and other SoxB1 genes and their partners.
Reports concerning the mechanisms of SOX3 regulation during neural differentiation are
limited and mainly focused on the transcriptional control of human SOX3 expression [1,12–
17]. In recent years, it was revealed that regulation of developmental genes with dynamic
expression patterns is not driven only by transcription factor networks, but also by the epigen-
ome (reviewed in [18,19]). Epigenetic regulation of gene expression is achieved through geno-
mic DNA methylation, post-translational modifications (PTMs) of histones, chromatin
remodeling and non-coding RNAs [19]. The complex interplay between these mechanisms
represents a mode in which genotype controls phenotype without changes in the DNA
sequence. Special efforts are made in an attempt to delineate epigenetic processes underlining
the formation of neurons, with an aim to improve stem cell based therapies in neurodegenera-
tive diseases, and to control commitment of pluripotent cells [20]. Epigenetic profiles of pluri-
potency-associated genes, such as Oct4, Sox2 and Nanog have been investigated in several
studies, and correlated with dynamic expression of these genes during development [21–23]
while epigenetic control of SOX3 expression remained to great extent understudied.
In the present study we have analyzed epigenetic modifications of the promoters of SOXB1
genes during early phases of retinoic acid (RA) induced neural differentiation of human
embryonal carcinoma NTera2/D1 (NT2/D1) cells with a special focus on SOX3 gene. We dem-
onstrate that the human SOX3 gene promoter is extremely hypomethylated both in undifferen-
tiated and RA-induced NT2/D1 cells and that it does not react to treatment with the
demethylating agent 5-azacytidine (5-azaC). Furthermore, by employing chromatin immuno-
precipitation (ChIP), we show that different regions of SOX3 gene are enriched in distinct
Epigenetic regulation of humanSOX3 gene
PLOSONE | https://doi.org/10.1371/journal.pone.0184099 September 8, 2017 2 / 27
Competing interests: The authors have declared
that no competing interests exist.
histone PTMs switching throughout the course of RA-induced neural differentiation. The pro-
files of histone modifications on the SOX3 promoter differ from those on the SOX1 and SOX2
promoters, implying that SOXB1 genes are controlled by different epigenetic mechanisms.
Materials andmethods
Cell culture and treatments
NT2/D1 cells, kindly provided by Prof. P.W. Andrews (University of Sheffield, UK) were
maintained in Dulbecco’s Modified Eagle’s medium (DMEM) supplemented with 10% fetal
bovine serum (FBS) 4500 mg/L glucose, 2 mmol/L L-glutamine and penicillin/streptomycin
(all from Invitrogen™, NY, USA), at 37˚C in 10% CO2 as previously described [24]. Cells were
induced to differentiate by addition of 10μmol/L all-trans retinoic acid (Sigma-Aldrich, MO,
USA) into the culture media and grown for 2, 4 and 7 days as previously described [24]. For
5-azacytidine treatment (5-azaC, Acros Organics, Belgium), cells were grown for 24h in
1 μmol/L 5-azaC.
Western blot
Western blot analyses of SOX3, SOX1 and SOX2 expression during RA induction were per-
formed on whole cell lysates (WCL) extracted from uninduced NT2/D1 cells and cells induced
with RA for 2, 4 and 7 days. For the analyses of SOX3 expression during treatments with 5-azaC
WCL were isolated from NT2/D1 cells and cells treated with 5-azaC. WCL were isolated and
western blots were performed as previously described [15] using anti-SOX3 (Abcam, ab42471),
anti-SOX1 (Abcam, ab109290), anti-SOX2 (Active Motif, 39823), anti-α-tubulin (Calbiochem,
DM1A) and anti- GAPDH (Abcam, ab9484), anti-caspase-3 (Cell Signaling, 9662), followed by
the incubation with horseradish peroxidase-conjugated anti-mouse and anti-rabbit IgG second-
ary antibodies (Amersham Biosciences, NJ, USA, diluted 1:10000). Immunoreactive bands were
detected by Immobilion Western Chemiluminescence substrate HRP (Millipore, MA, USA).
Density of protein bands on blots were quantified using ImageJ software (https://imagej.nih.
gov/). Data from at least 3 independent experiments were normalized by the amount of α-tubu-
lin and presented relative to the corresponding value for untreated cells.
Real time PCR analysis
Total RNA was isolated using TRI-Reagent (Ambion, Invitrogen,USA) according to the manu-
facturer’s instructions. RNA was treated with DNaseI using a DNA-Free™ kit (Ambion, Invi-
trogen, USA) and subjected to cDNA synthesis. Total RNA (1 μg) was reverse transcribed
using High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, USA) according
to the manufacturer’s protocol. cDNAs were subjected to real time PCR using Power SYBR
Green PCR Master Mix (Applied Biosystems, USA) in 7500 Real Time PCR Systems (Applied
Biosystems, USA). Following primers were used:
SOX3
5’- GGGGAGGGCTGAAAGTTTTG-3’(forward)
5’- ACACAGCGATTCCCAGCCTA-3’(reverse)
Nanog
5’- GGTCCCGGTCAAGAAACAGA-3’ (forward)
5’- TCTGGAACCAGGTCTTCACC-3’ (reverse)
Epigenetic regulation of humanSOX3 gene
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Dbx1
5’- AAGCTGGGCCTGAAAGACTC-3’ (forward)
5’- CCTCCTCCTCCTCTTCGTTC-3’ (reverse)
SOX2
5’- CCCCTGGCATGGCTCTTGGC-3’ (forward)
5’- TCGGCGCCGGGGAGATACAT-3’ (reverse)
GAPDH
5’- GGACCTGACCTGCCGTCTAG-3’ (forward)
5’- CCACCACCCTGTTGCTGTAG-3’ (reverse)
All samples were measured in triplicate and the mean value was considered. The relative
levels of SOX3, SOX2 and Nanog expression were determined using a comparative quantifica-
tion algorithm where the resulting ΔΔCt value was incorporated to determine the fold differ-
ence in expression (2−ΔΔCt). Relative SOX3, SOX2 and Nanog mRNA levels were presented as a
fold change in gene expression normalized to GAPDH and relative to the value in untreated
NT2/D1 cells, which was set as 1. The expression level of Dbx1 was analyzed as 2−ΔCt due to the
low levels of Dbx1 mRNA in undifferentiated NT2/D1 cells.
Immunostaining
NT2/D1 cells were plated on coverslips and cultured in the absence (for 2 days) or presence
(for 2, 4 and 7 days) of RA. Following fixation in 4% paraformaldehyde for 20 min at room
temperature and permeabilization in 0.1% Triton X 100, cells were incubated in blocking solu-
tion, 10% normal goat serum and 1% bovine serum albumin (BSA) in PBS for 1 h at room
temperature. Primary antibodies diluted in 1% BSA (Sigma Aldrich, USA), 0.1% Triton X 100
in PBS were applied overnight at 4˚C as follows: mouse monoclonal anti OCT-3/4 (sc-5279,
diluted 1: 100; Santa Cruz Biotechnology, Inc) and rabbit polyclonal anti SOX3 (sc-20089,
diluted 1: 100; Santa Cruz Biotechnology, Inc). Coverslips were washed three times for 10 min
in 0.1% Triton X 100 in PBS and incubated with biotinylated goat anti rabbit IgG (1: 500; Vec-
tor, USA) for 1 h at room temperature in 1% BSA, 0.1% Triton X 100 in PBS followed by
DyLight 4881 streptavidin (1: 1000; Vector Laboratories, USA) and Alexa FluorH 594, (1: 500;
InvitrogenTM) diluted in PBS for 1 h at room temperature. Nuclei were stained with 0.1 mg/
ml 40,6 diamino phenylindole (DAPI; Sigma Aldrich). Samples were viewed and images were
taken using a Leica TCS SP8 confocal microscope and Leica Microsystems LAS AF TCS SP8
software (Leica Microsystems, Germany).
RT-PCR analysis
Total RNA was isolated, subjected to DNaseI treatment and reversely transcribed as described
in previous subsection. The synthetised cDNAs were used as templates for PCR amplifications
with primers specific for SOX1 and GAPDH (as in previous subsection) as a loading control.
Primers for SOX1 amplification were as follows:
5’- GCACCACTACGACTTAGTCCG-3’ (forward)
5’- AGACCTAGATGCCAACAATTGG -3’ (reverse)
Epigenetic regulation of humanSOX3 gene
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RT-PCRs were performed in 20 ul reactions using KAPA 2G Fast HotStart Ready Mix
(Kapa Biosystems) according to manufacturer’s protocol. Obtained products were separated
electrophoretically on 2% agarose gel and visualized using ethidium bromide staining. Quanti-
fication of obtained bands was performed using ImageJ software (https://imagej.nih.gov/ij/).
Methylation-specific PCR
For MSP analyses, direct sodium-bisulfite conversion of uninduced NT2/D1 cells and cells
induced with RA for 2, 4 and 7 days was performed using EZ DNA Methylation-Direct™ Kit
(Zymo Research Corporation, CA, USA). For each conversion 105 cells were used and protocol
provided by the manufacturer strictly followed. Upon conversion the reaction recovery rate
was considered as 100% and hence concentration of DNA was not measured. Converted DNA
samples were used as templates for PCR amplification using KAPA 2G Fast HotStart Ready
Mix (Kapa Biosystems) and cycling conditions 95˚C for 5 minutes; 95˚C for 30 seconds, 60˚C
for 20 seconds, 72˚C for 2 minutes, for 35 cycles. MSP primers were designed using MethPri-
mer web-based tool [25]. Following primers were used for amplification of methylated (M)
versus unmethylated (U) SOX3 gene promoter sequence:
M:
5'- GTAGATTGTGAATGCGATTTGTTC-3'
5'- GATAAAAAAACCCTAAAACTCCGTC -3'
U:
5'- GGTAGATTGTGAATGTGATTTGTTT -3'
5'- ACAATAAAAAAACCCTAAAACTCCAT -3'
For MSP analysis of SOX1 gene promoter following primers were used for amplification of
methylated (M) versus unmethylated (U) sequence:
M:
5'- AATTTTTTATTTGCGAGTCGAATC-3'
5'- AAAAACCTAAAACATAAACGACCG-3'
U:
5'- GAAATTTTTTATTTGTGAGTTGAATTG -3'
5'- AAAACCTAAAACATAAACAACCAAA -3'
Obtained products were separated electrophoretically on 2% agarose gel and visualized
using ethidium bromide staining.
Extraction and sodium-bisulfite conversion of genomic DNA
Pellets collected from uninduced NT2/D1 cells and cells induced with RA for 2, 4 and 7 days
were resuspended in TSM buffer [140 mM NaCl, 10 mM Tris (pH 7.4), 1.5 mM MgCl2, 0.5%
NP40]. After short centrifugation, pellets were lysed in nuclei dropping buffer (75 mM NaCl,
24 mM EDTA, 0.2mg/ml proteinase K, 0.5% SDS). High molecular weight DNA was extracted
using phenol-chlorophorm-isoamylalcohol extraction, and precipitated with sodium acetate
and isopropanol.
Epigenetic regulation of humanSOX3 gene
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Sodium-bisulfite conversion of isolated genomic DNA was performed using EZ DNA
Methylation-Lightning™ Kit (Zymo Research Corporation, CA, USA). For each conversion
2 μg of DNA was used and protocol provided by the manufacturer strictly followed. Upon con-
version the reaction recovery rate was considered as 100% and hence concentration of DNA
was not measured.
PCR amplification of bisulfite convertedSOX3 promoter
PCRs were performed in 60 μl reactions using KAPA 2G Fast HotStart Ready Mix (Kapa Bio-
systems) according to the manufacturer’s protocol. Bisulfite converted DNA from uninduced
NT2/D1 cells and cells induced for 2, 4 and 7 days with RA were used as a template to amplify
2nd CpG island within SOX3 promoter. PCR cycling conditions were 95˚C for 10 minutes;
95˚C for 20 seconds, 50–55˚C for 20 seconds, 60˚C for 2 minutes, for 40 cycles. PCR reactions
were performed using non-modified forward primer and 5’-biotin-labeled reverse primer
listed below. BSP primers were designed using MethPrimer tool [25]. Indicated primers posi-
tions were determined relative to TSS.
2nd CpG island:
5’-AAGGGGTTTAGTTAGAGTTTA-3’ (-6 to +15)
5’-AATCTCCAAAAAACTATACAT-3’ (+253 to 273)
Pyrosequencing
Pyrosequencing of amplified biotinylated PCR products was performed by commercial service
at Queen Mary University of London, Genome Centre, London on Pyromark MD system, Bio-
tage (Qiagen Pyrosequencing for 2nd CpG island was performed with primers:
SEQ3
5’-TTTAGGTAGATTGTGAATG-3’
SEQ4
5’-TTGGTTTATAGGTTTTTAAG-3’
In the obtained pyrograms, the amount of C relative to the sum of the amounts of C and T
at each CpG site is calculated as percentage of methylation level of indicated CpG site. Total
methylation levels of 2nd CpG island within SOX3 promoter were calculated as average values
of every individual CpG sites methylation levels.
Chromatin immunoprecipitation
Untreated NT2/D1 cells and NT2/D1 cells treated with 10 μM RA for 2, 4 and 7 days were
crosslinked with 1% formaldehyde in DMEM for 10 minutes at room temperature and rinsed
with cold PBS. Crosslinking reaction was stopped with 0.125 mM glycine in cold PBS for 5
minutes. Cells were lysed with lysis buffer [5 mM Pipes (pH 8.0), 85 mM KCl, 0.5% NP-40,
Protease inhibitor cocktail]. Cells were dounced on ice and nuclei separated by centrifugation.
Nuclei were lysed in sonication buffer (50 mM Tris pH 8.0, 10 mM EDTA, 0.1% SDS, 0.5%
deoxycholic acid, Protease inhibitor cocktail (Roche Diagnostics GmbH, Switzerland)]. Chro-
matin was sonicated to fragments of 500–1500 bp. Precleared chromatin in immunoprecipita-
tion buffer [50 mM Tris (pH 8.0), 10 mM EDTA, 0.1% SDS, 0.5% deoxycholic acid, 150 mM
Epigenetic regulation of humanSOX3 gene
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LiCl, Protease inhibitor cocktail (Roche Diagnostics GmbH)] was incubated overnight with
following antibodies: anti-Flag (Sigma Aldrich, F3165), anti-H3 (Abcam, 1791), anti-
H3K4me3 (Active Motif, 39159), anti-H3K79me2 (Abcam, 3594), anti-H2B (Abcam, 1790),
anti-H2BK16ac (Active Motif, 39121), anti-H2BK120ac (Active Motif, 39119), anti-H2BK5ac
(Active Motif, 39123). Following day, chromatin and antibodies were incubated for 4 hours
with Protein G agarose (KPL, USA) saturated with salmon sperm DNA and BSA overnight.
Samples were centrifugated and Flag supernantants saved for Inputs. Resins were washed 5
times with RIPA buffer [10 mM Tris (pH 8.0), 1 mM EDTA, 0.5 mM EGTA, 0.1% SDS, 0.1%
deoxycholic acid, 140 mM NaCl, 1% Triton X-100, Protease inhibitor cocktail(Roche Diagnos-
tics GmbH, USA), 1 mM PMSF], followed by wash with LiCl buffer [0.25 M LiCL, 0.5% NP-
40, 0.5% deoxycholic acid, 10 mM Tris (pH 8.0), 1 mM EDTA] and wash in TE buffer, pH 8.0.
Resins were resuspended in TE buffer, and cross-links reversed by overnight incubation with
RNase A (Sigma Aldrich, MO, USA) at 65˚C. Following day all samples were adjusted to 0.5%
SDS and treated with 20 μg of Proteinase K (Sigma Aldrich, MO, USA) for immunoprecipi-
tated samples and 40 μg for Input samples for 3 hours at 50˚C. DNA was extracted with phe-
nol/chlorophorm/isoamylalcohol and precipitated overnight at -20˚C with 3M sodium-
acetate, tRNA (Sigma Aldrich, MO, USA) and ethanol. Following day DNA samples were cen-
trifuged and DNA resuspended in H2O.
DNA sequences of SOX3 (RefSeq NM_005634) upstream (-673/-578), SOX3 core promoter
(-224/-63), SOX3 5’ downstream coding region (+503/+606), SOX2 (RefSeq NM_003106) pro-
moter (-107/+56) and SOX1 (RefSeq NM_005986) promoter (-147/+25) were analyzed using
qPCR with following primers:
SOX3 upstream
5’–GCAGTCCTGAAGCCTGTCTC-3’ (forward)
5’–GCGTCTCCAAGAAGCTCTCC-3’ (reverse)
SOX3 core promoter
5’- AGGGCTCCCCGAACTTTT-3’(forward)
5’- GCTGGGCCCCTTATATACCT-3’(reverse)
SOX3 downstream
5’- TGGAGAACCCCAAGATGCAC-3’(forward)
5’- CTTGGCCTCGTCGATGAATG-3’(reverse)
SOX2 promoter
5’- GCCCCCTTTCATGCAAAACC-3’(forward)
5’- CTCTGCCTTGACAACTCCTG-3’(reverse)
SOX1 promoter
5’- ACCCCTCCCCATTCTTCTCT-3’(forward)
5’- CAGGTCGGTCTCCATCATCA-3’(reverse)
The enrichment was calculated relative to Flag and normalized against H3 or H2B. In com-
parative experiments, the enrichment in undifferentiated cells was assigned the value 1 and
other samples were normalized to this value [26]. Results are representative of duplicated
qPCR reactions from three ChIP experiments (biological replicates).
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Statistics
Data were presented as mean ± S.D. and were analyzed using Student’s T test. P<0.05 was
considered statistically significant.
Results
Analysis of human SOX3 gene expression during early phases of neural
differentiation of NT2/D1 cells
SOX3 is considered as one of the key regulators of neural development in vertebrates [27].
We analyzed its expression in the early stage of RA-induced neural differentiation of NT2/
D1 cells. Due to their similarity with hESC and the property to differentiate into morpholog-
ically and physiologically mature neurons after exposure to RA, NT2/D1 cells represent an
appropriate in vitro model to study the process of human neural differentiation [24,28,29].
Although derived from human teratocarcinoma, these cells display properties of neural pro-
genitor cells [30]. Following induction with RA, NT2/D1 cells loose expression of neuroe-
pithelial markers and acquire expression of neuronal markers, yielding NT2N neurons that
maintain a stable neuronal phenotype, form functional synapses, do not divide, and there-
fore have been used in various studies as an alternative graft sources in transplantation ther-
apy for ischemia [30,31]. Moreover, in our previous studies and reports made by other
groups, NT2/D1 cell line was used for the analyses of human SOX genes expression and reg-
ulation [12–15,17,23,32–37]. We have previously shown that the treatment of NT2/D1 cells
with RA triggered an early (48h) increase in the expression of SOX3 gene [35]. In the present
study, we have expanded this analysis by following SOX3 expression in longer time points (4
and 7 days). By qRT-PCR and Western blot, we demonstrate significant upregulation of
SOX3 after exposure of NT2/D1 cells to RA, at the mRNA (Fig 1A) and protein levels (Fig
1B). SOX3 shows a peak at 2 days of RA treatment, followed by decrease in protein and
mRNA levels (Fig 1A and 1B).
To verify pluripotency of NT2/D1 cells and confirm the differentiation status after RA
induction, we analyzed the expression of Nanog, one of the core pluripotency factors [38]. We
also analyzed the expression of Dbx1, a homeodomain protein with a critical role in the estab-
lishment of V0 and V1 interneurons [39] and a direct target of Sox3 in neural precursors [9].
We observed a significant decrease in Nanog mRNA levels 4 days following RA treatment,
confirming the exit of NT2/D1 cells from the pluripotency (Fig 1C). At day 4, the cells show
upregulated expression levels of Dbx1 (Fig 1C). Thus, the expression patterns of SOX3, Nanog
and Dbx1 confirm the onset of neural fate commitment.
In order to further examine the temporal pattern of SOX3 protein expression during
early phases of neural differentiation in our model system, we analyzed its co-expression
with stemness marker OCT4 by immunocytochemistry. We have previously demonstrated
that OCT4, together with Nanog, is downregulated during the first week of neural differenti-
ation of NT2/D1 cells [34]. Herein, we confirmed that strong OCT4 immunoreactivity
detected in undifferentiated NT2/D1 cells (Fig 2A2 and 2A4) declined in most of the cells
following 2 (Fig 2B2 and 2B4) and 4 days (Fig 2C2 and 2C4), but almost completely disap-
peared after 7 days of RA induction (Fig 2D2 and 2D4). As shown in Fig 2, we detected a low
level of SOX3 protein expression in NT2/D1 cells prior to the differentiation (Fig 2A1 and
2A4) that sharply increased after 2 days of RA treatment. Induction of SOX3 in most of the
cells coincided with reduced level of OCT4 protein expression suggesting that these two
transcription factors are oppositely regulated at initial periods of neural differentiation (Fig
2, arrowheads in B1, B2, B3, B4). However, as differentiation proceeded, only populations of
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cells which retained medium OCT4 protein expression level were also immunoreactive for
SOX3 (Fig 2, arrows in C1, C2, C3, C4). Finally, at the end of the differentiation protocol, at
day 7, expression level of SOX3 was barely detectable (Fig 2D1 and 2D4). Taken together,
our results demonstrated that SOX3 protein is transiently expressed in specific developmen-
tal stage of NT2/D1 cells during initiating phases of in vitro neural differentiation. This
prompted us to further investigate possible epigenetic mechanisms implicated in the regula-
tion of SOX3 expression.
Fig 1. SOX3 is upregulated during early phases of RA induced neural differentiation of NT2/D1 cells.
(A) Real-time PCR analysis of SOX3 expression in untreated and RA treated NT2/D1 cells (2, 4 and 7 days).
Data were normalized by the amount ofGAPDHmRNA and presented relative to the corresponding value for
untreated cells, and are means ± S.D.,*P<0.05 from triplicate data. (B) Western blot analysis of SOX3 protein
in whole cell lysates of untreated and NT2/D1 cells treated with RA for 2, 4 and 7 days. SOX3 protein
quantities were expressed relative to untreated NT2/D1 cells (set at 1) and presented as mean ± S.D. of at
least three independent experiments; *P<0.05. α-tubulin was used as loading control. Representative blots
are shown. (C) Real-time PCR analyses of pluripotencymarkerNanog and neural markerDbx1 expression
patterns during early phases of RA induced neural differentiation of NT2/D1 cells.Nanog expression data
were normalized by the amount ofGAPDHmRNA and presented relative to the corresponding value for
untreated cells, and are means ± S.D., *P<0.05 from triplicate data.Dbx1 expression levels were normalized
by the amount ofGAPDHmRNA and calculated as 2-Δct. Data are presented as means ± S.D., *P<0.05 from
triplicate data.
https://doi.org/10.1371/journal.pone.0184099.g001
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In silico analysis of humanSOX3 promoter
Functionally, the promoter of human SOX3 gene is 713 bp in length [12] and we analyzed it
with the MethPrimer tool [25]. The analysis was conducted using default criteria for CpG
island prediction, and it has revealed the presence of 2 CpG islands within the human SOX3
promoter (Fig 3A). The island with 17 CpGs dinucleotides (from 209–423 bps) corresponds
approximately to the minimal SOX3 promoter [12], while the second CpG island with 22
CpGs (434–657 bps) encompasses the SOX3 TSS ending downstream of the second ATG
codon (Fig 3A) [12].
Fig 2. Immunocytochemical co-localization of SOX3 and OCT4 during early phases of RA-induced
neural differentiation of NT2/D1 cells. Immunocytochemical detection of SOX3 andOCT4 in untreated NT2/
D1 cells (A1-A4) and NT2/D1 cells treated with RA for 2 (B1-B4), 4 (C1-C4), and 7 (D1-D4) days. Cells with high
level of SOX3/low level of OCT4 expression are designated by white arrowheads in panels B1-B4. Cells with low
level of SOX3/high level of OCT4 expression are designated by yellow arrowheads in panels B1-B4. Cells that
are highly imunopositive for both markers are designated by white arrows in panels C1-C4. Cell nuclei were
stained with DAPI (A3, B3, C3, D3). Scale bar: 50 μm.
https://doi.org/10.1371/journal.pone.0184099.g002
Epigenetic regulation of humanSOX3 gene
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The methylation profile of SOX3 promoter during early phases of neural
differentiation
We sought to determine potential dynamic changes in the methylation levels of these CpG
islands during the early phases of neural differentiation of NT2/D1 cells. First, we have
employed methylation-specific PCR (MSP) to assess methylation status of the human SOX3
promoter in undifferentiated NT2/D1 cells and cells treated with RA for 2, 4 and 7. While the
1st CpG island could not be subjected to MSP analysis due to the sequence-based difficulties in
MSP primers design, 2nd CpG island was successfully amplified. As shown in Fig 3B, products
Fig 3. Human SOX3 promoter is hypomethylated during early phases of neural differentiation of NT2/
D1 cells. (A) CpG islands localization within the humanSOX3 promoter determined by MethPrimer online
software. Arrows I and II indicate CpG island regions. BellowMethPrimer graph is a schematic representation
of the humanSOX3 promoter and regions analyzed usingMSP and pyrosequencing (Pyro S). Individual
CpGs are represented as black dots. Numbers represent end points of the analyzed promoter region relative
to tss (+1). (B) Analysis of SOX3 promoter methylation in untreated (NT2/D1) and cells treated with RA in
indicated time points (2, 4 and 7 days) by MSP. Product obtainedwith primers corresponding to methylated
(M) 2nd CpG islandwithinSOX3 promoter and product obtainedwith primers corresponding to unmethylated
(U) 2nd CpG islandwithinSOX3 promoter were separated on agarose gel. (C) Quantitative analysis of SOX3
promotermethylation in untreated (NT2/D1) and cells treated with RA in indicated time points (2, 4 and 7
days) by pyrosequencing of the 2nd CpG island. Bars indicatemean levels of methylation of SOX3 promoter in
each time point. (D) Effects of 1μM5-azaC treatment on the expression of SOX3 protein in NT2/D1 cells.
Quantity of SOX3 protein in treated cells was calculated relative to untreated NT2/D1 cells (set at 1) and
presented as the means ± S.D. of at least three independent experiments; *P<0.05. Caspase-3 expression
was used as a positive control. Representative blots are shown.
https://doi.org/10.1371/journal.pone.0184099.g003
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obtained with primer set corresponding to unmethylated DNA were highly abundant, in com-
parison with products obtained with primer set corresponding to methylated DNA. These
results suggested that second CpG island within the SOX3 promoter is unmethylated in undif-
ferentiated NT2/D1 cells and that this hypomethylation is sustained during RA-induction of
these cells. In order to elucidate these findings in more detail, we employed bisulfite
pyrosequencing.
We found 1st CpG island to be difficult for the analysis due to GC-rich sequence which
could give rise to homopolymers and secondary structures following bisulfite conversion of
DNA. These structures prevent optimal amplification and subsequent pyrosequencing of the
region encompassing 1st CpG island within the SOX3 promoter and therefore we proceeded
with the analysis of the second island. Genomic DNA isolated from undifferentiated NT2/D1
cells and cells treated with RA for 2, 4 and 7 days were subjected to the sodium-bisulfite con-
version. Converted DNA was used as a template to amplify 2nd CpG island within SOX3 pro-
moter using non-modified forward primer and biotin-labeled reverse primer and PCR
products were analyzed by pyrosequencing [40]. We demonstrated hypomethylation of the
SOX3 promoter in undifferentiated NT2/D1 cells (Fig 3C), which is preserved during RA-
induced neural differentiation (Fig 3C). Average methylation of SOX3 does not exceed 10% at
all timepoints analyzed, as shown in Fig 3C. The data suggest that methylation of SOX3 does
not correlate with the dynamic changes of SOX3 expression during the initial phases of neural
differentiation.
In order to confirm these data, we treated NT2/D1 cells with 5-azaC, a demethylating agent
acting during DNA replication and cell division [41,42] followed by the analysis of the SOX3
expression levels (Fig 3D). Endogenous caspase-3, previously shown to be upregulated follow-
ing treatment of NT2/D1 cells with nucleoside drugs [43], was used as a positive control (Fig
3D). As expected, treatment with 5-azaC did not induce any significant change in SOX3 pro-
tein levels (Fig 3D). The lack of upregulation of the SOX3 protein expression upon exposure to
5-azaC further supports the idea that methylation is not a mechanism governing RA-induced
activation of SOX3 expression in NT2/D1 cells.
Histonemodifications profiles on SOX3 gene during early phases of RA-
induced neural differentiation of NT2/D1 cells
Numerous reports highlighted the importance of histone covalent PTMs in the control of
nucleosome dynamics during the process of differentiation induced by the environmental sti-
muli [44]. In order to check the status of histone modifications in the SOX3 gene in pluripotent
cells, we examined ChIP-Seq reads in human ES cell line H1 (H1-hESC) using ENCODE data-
sets (Fig 4) (GRCh37/hg19; http://genome.ucsc.edu). ChIP-Seq signals for H3K4me2 and
H3K4me3 in the promoter and the SOX3 coding region are high (Fig 4). Other markers are
absent from the SOX3 promoter (H3K9ac and H3K27ac) and coding region (H3K36me3 and
H4K20me1), and H3K79m2 is low within the coding region (Fig 4). Furthermore, H3K27me3
overlaps with the 3’ region, but it is not present at the SOX3 promoter (Fig 4). These histone
signatures indicate permissive promoter with low transcriptional activity in pluripotent cells,
consistent with low expression levels of SOX3 in hESCs [10].
In order to investigate histone modifications on SOX3 during neural differentiation of
NT2/D1, we employed ChIP using a range of specific antibodies, monitoring by qPCR three
regions: a region ~600bp upstream of the TSS (SOX3 upstream), the SOX3 core promoter and
a region within SOX3 gene, ~550bp downstream from TSS (SOX3 downstream) (Fig 5A). We
detected enrichment of H3K4me3 on the core promoter region (Fig 5B). Upon RA-induction
the level of H3K4me3 increased 1.6 times on the SOX3 core promoter within the first 2 days of
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RA induction, followed by a statistically significant drop at days 4 and 7 (Fig 5B). This profile
mirrors the expression levels of the SOX3 gene (Fig 1A and 1B), providing evidence of a link
between H3K4me3 and SOX3 transcription. Moreover, the region upstream of the SOX3 TSS
is undergoing similar, but less prominent changes in H3K4me3 levels during the course of dif-
ferentiation (Fig 5B).
Next, we investigated profiles of H2B acetylation of lysine residues 5, 16 and 120 (Fig 5C–
5E). It has been shown that acetylation of histones neutralizes lysine charges, thus affecting
nucleosome stability and promoting DNA accessibility and transcriptional activation [45,46].
We demonstrate a statistically significant decrease in the levels of H2BK16ac, H2BK120ac and
H2BK5ac on the core promoter of the SOX3 gene throughout the course of RA induction of
Fig 4. UCSCgenome browser tracks showing histonemodifications around SOX3 locus in H1-hESCs. Shown from top to bottom
is layered H2A.Z mark; enhancer- and promoter-associated H3K4me1, H3K4me2 and H3K4me3marks; active marks H3K9ac,
H3K9me3 andH3K27ac; repressivemark H3K27me3;marks associatedwith coding regions H3K36me3, H3K79me2 and H4K20me1.
Arrows in the first track depict direction of transcription.
https://doi.org/10.1371/journal.pone.0184099.g004
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NT2/D1 cells (Fig 5C–5E). Surprisingly, we did not observe an increase in H2B acetylation 2
days after RA introduction, the time point corresponding to the highest SOX3 promoter activ-
ity. We analyzed the region upstream of SOX3 TSS and observed changes in the H2B acetyla-
tion levels (Fig 5C–5E) correlating with the expression profile of SOX3 (Fig 1A and 1B).
In the SOX3 coding region, we detected a profile of H3K4me3 similar to the core promoter
with more prominent increase on day 2 of RA-induction (Fig 5B). We speculate this increase
is a reflection of equivalent changes in this mark on the promoter throughout the course of
early differentiation. It has been demonstrated that activated transcription affects the levels of
H3K4me3 in coding regions of genes and it is accompanied by the shift in the distribution of
this mark on the promoter and coding region [47]. Moreover, the profiles of H2B acetylation
in the coding region are similar to the ones in the core promoter, with lower abundance of all
three marks at days 4 and 7 of RA-induction (Fig 5C–5E). Finally, in the coding region of
SOX3 gene we analyzed the pattern of H3K79me2, a mark associated with elongating RNA Pol
Fig 5. ChIP-qPCR analysis of SOX3 regulatory regions. (A) Schematic representation of the humanSOX3
gene indicating SOX3 upstream (left tile), SOX3 core promoter (center tile) andSOX3 downstream (right tile)
regions analyzed by ChIP. The positions of analyzed regions, relative to TSS, are indicated. (B-F) ChIP-qPCR
results for the indicated histonemodification that correspond to SOX3 regions presented above. The
enrichment was calculated relative to Flag and normalized against H3 or H2B. In comparative experiments,
the enrichment in undifferentiated cells was assigned the value 1 and other samples were normalized to this
value. Each ChIP experiment was repeated three times (biological replicates) followed by duplicate qPCR
reactions. Results are presented as themean ± S.D., *P<0.05.
https://doi.org/10.1371/journal.pone.0184099.g005
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II [48,49], and observed an increase after the induction of neural differentiation (Fig 5F).
These findings are consistent with the existing data indicating that this modification is
enriched in exons and drives the elongation phase of the transcription [48]. Interestingly, the
levels of H3K79me2 remain significantly higher, 4-fold approximately, even at day 7 of RA-
induction, a time point with the lowest SOX3 expression.
Analysis of human SOX1 gene expression, methylation status and
histonemodifications profiles during the early phases of neural
differentiation of NT2/D1 cells
We analyzed the expression pattern of SOX1/SOX1 mRNA and protein levels in differentiating
NT2/D1 cells. As shown in Fig 6, we detected low levels of SOX1 mRNA (Fig 6B) and SOX1
Fig 6. SOX1 is upregulated and hypomethylated during early phases of RA induced neural
differentiation of NT2/D1 cells. (A) Analysis of SOX1 promoter methylation in untreated (NT2/D1) and cells
treated with RA in indicated time points (2, 4 and 7 days) by MSP. Product obtainedwith primers
corresponding to methylated (M) SOX1 promoter and product obtainedwith primers corresponding to
unmethylated (U) SOX1 promoter were separated on agarose gel. (B) RT-PCR analysis of SOX1 expression
in untreated and RA treated NT2/D1 cells (2, 4 and 7 days). Data were normalized by the amount ofGAPDH
mRNA and presented relative to the corresponding value for untreated cells, and are means ± S.D., *P<0.05
from triplicate data. (C)Western blot analysis of SOX1 protein in whole cell lysates of untreated and NT2/D1
cells treated with RA for 2, 4 and 7 days. SOX1 protein quantities were expressed relative to untreated NT2/
D1 cells (set at 1) and presented as mean ± S.D. of at least three independent experiments; *P<0.05. α-
tubulin was used as loading control. Representative blots are shown.
https://doi.org/10.1371/journal.pone.0184099.g006
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protein (Fig 6C) in uninduced NT2/D1 cells. At day 4 of RA treatment significant increase in
SOX1/SOX1 mRNA and protein levels was observed and remained high in the day 7 of neural
differentiation. This is in line with other studies which specified Sox1/SOX1 as an early
responder to neural inducing signals and one of the early markers of neural induction [50–52].
Regarding the methylation status of SOX1 gene, data are limited to various types of cancers
[53–55], while for neural differentiation experimental data are lacking. Thus, we proceeded
with the MSP analysis of the methylation status of SOX1 gene promoter during the neural dif-
ferentiation of NT2/D1 cells. We detected products obtained with primer set corresponding to
unmethylated DNA, while the products obtained with primer set corresponding to methylated
DNA were absent, as shown in Fig 6A. These results indicated that SOX1 promoter has a low
methylation level in both undifferentiated NT2/D1 cells, as well as during the following days of
RA-induced neural differentiation, similar to methylation profiles obtained for SOX3
promoter.
The analyses of histone PTMs revealed increase in H3K4me3 abundance on the promoter
of SOX1 at day 2 of RA induction (Fig 7B). In following days of RA treatment we observed
slight drop in the enrichment of H3K4me3, indicating that this histone mark is not in correla-
tion with the detected transcriptional activation of SOX1. As for H2B modifications, promi-
nent decline in H2BK16ac, H2BK120ac and H2BK5ac levels accompanied RA-induced neural
differentiation of the cells (Fig 7B). These data suggest that selected H2B acetyl marks do not
contribute to the enhanced SOX1 expression following RA induction.
Analysis of human SOX2 gene expression and histonemodifications
profiles during the early phases of neural differentiation of NT2/D1 cells
We analyzed the expression pattern of SOX2/SOX2 mRNA and protein levels in differentiating
NT2/D1 cells. As shown in Fig 8, we detected a significant drop in SOX2/SOX2 mRNA and
protein levels 2 days after exposure to RA, with no further decline in the following days (Fig
8A and 8B). This is consistent with the exit from pluripotency and activation of the neural pro-
gram [35]. It also coincides with the increase in SOX3 expression, indicating that SOX2 and
SOX3 are differentially regulated. Numerous studies have demonstrated that the regulatory
regions of SOX2 are nonmethylated during the course of neural differentiation of embryonal
carcinoma cells [23,56] suggesting that the changes of SOX2 expression during neural differen-
tiation are independent of DNA methylation.
As for histone PTMs, we detected high level of H3K4me3 on the human SOX2 promoter,
consistent with the previous studies performed in mouse and human ESCs [57–59], as well as
high levels of H2BK16ac, H2BK120ac and H2BK5ac. Following treatment of NT2/D1 cells
with RA, we observed a slight decrease in H3K4me3, H2BK16ac and H2BK120ac (Fig 9). The
most prominent change was in H2BK5ac, which declined on day 2 of differentiation (Fig 9).
This coincides with the decrease of SOX2 expression (Fig 8), suggesting that deacetylation of
H2BK5 is one of the marks associated to the response of the SOX2 promoter to the RA. The
SOX2 promoter is showing an opposite profile of H2BK5ac compared to SOX3 at day 2, which
implies that these two genes have different epigenetic regulation (Figs 5 and 9).
Bioinformatic analyses of human SOXB1 genes expression and histone
modifications profiles in H1-ESCs and H1-derived neural progenitors
In order to assess expression and histone PTMs profiles of SOXB1 genes in another model sys-
tem, we performed bioinformatics analysis of genome-wide data available from http://www.
roadmapepigenomics.org/ for H1-ESCs and H1-derived neural progenitors. Data are pre-
sented in S1 Fig. Furthermore, expression data obtained in the present study are in line with
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Fig 7. ChIP-qPCR analysis of the SOX1 core promoter. (A) Schematic representation of the humanSOX1
core promoter analyzed by ChIP. The positions of the region relative to TSS are indicated. (B) ChIP-qPCR
results for the indicated histonemodifications. The enrichment was calculated relative to Flag and normalized
against H3 or H2B. In comparative experiments, the enrichment in undifferentiated cells was assigned the value
1 and other samples were normalized to this value. Each ChIP experiment was repeated three times (biological
replicates) followed by duplicate qPCR reactions. Results are presented as themean ±S.D., *P<0.05.
https://doi.org/10.1371/journal.pone.0184099.g007
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RNA-Seq analyses of expression of SoxB1 mRNAs during RA-induced neuronal differentia-
tion of mESCs [60].
Discussion
Despite the growing amount of data regarding the regulation of the human SOX3 gene expres-
sion and activity in pluripotent cells and their differentiated progeny, reports concerning the
epigenetic mechanisms of its regulation during the process of differentiation are limited. Lin-
deman et al. revealed that regulatory sequences of the Sox3 zebrafish orthologue are methyl-
ated and low in positive histone PTMs in somatic cells, compared to midblastula transition
(MBT) cells, characterized by high expression of Sox3, lack of DNA methylation and positive
histone PTMs [61]. Epigenetic regulation of Sox3 has also been discussed as part of study by
Azuara et al. [59] showing that markers of active and repressive chromatin are simultaneously
present at silent tissue-specific genes, such as Sox3, in mESCs. Finally, hypermethylation of
SOX3 was detected in chronic lymphocyte leukemia [62].
Embryonal carcinoma cell line NT2/D1 provided us with a valuable model system to study
the epigenetic state of SOX3 gene in pluripotent cells as well as in cells responding to neural
differentiation-inducing stimuli. Molecular events during RA induced differentiation of NT2/
D1 cells reflect the steps in the development of human brain [63]. We demonstrated that the
initial phases of RA treatment are critical for the transcriptional activity of SOX3 [17,32,35].
Two days after RA introduction, we detected a significant increase in SOX3 mRNA and pro-
tein, thereafter, downregulation ensued. This profile resembles the one previously detected in
the chicken and mouse neuroepithelium during early phases of neural induction, with tran-
sient upregulation of Sox3 gene [64–66].
Despite low SOX3 expression levels in undifferentiated cells, the SOX3 promoter is hypo-
methylated. This hypomethylation persists through neural differentiation induced by RA.
Fig 8. SOX2 is down-regulated during early phases of RA induced neural differentiation of NT2/D1
cells. (A) Real-time PCR analysis of SOX2 gene expression in untreated and RA treated NT2/D1 cells (2, 4
and 7 days of induction). Data were normalized by the amount ofGAPDHmRNA and presented relative to the
corresponding value for untreated cells, and are means ± S.D., *P<0.05 from triplicate data. (B) Western blot
analysis of SOX2 protein in whole cell lysates of untreated and NT2/D1 cells treated with RA for 2, 4 and 7
days. SOX2 protein quantities were expressed relative to untreated NT2/D1 cells (set at 1) and presented as
the mean ± S.D. of at least three independent experiments, *P<0.05. α-tubulin was used as loading control.
Representative blots are shown.
https://doi.org/10.1371/journal.pone.0184099.g008
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Fig 9. ChIP-qPCR analysis of the SOX2 core promoter. Schematic representation of the humanSOX2 core
promoter analyzed by ChIP. The positions of the region relative to TSS are indicated. (B) ChIP-qPCR results
for the indicated histonemodifications. The enrichment was calculated relative to Flag and normalized against
H3 or H2B. In comparative experiments, the enrichment in undifferentiated cells was assigned the value 1 and
other samples were normalized to this value. Each ChIP experiment was repeated three times (biological
replicates) followed by duplicate qPCR reactions. Results are presented as themean ±S.D., *P<0.05.
https://doi.org/10.1371/journal.pone.0184099.g009
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Similar results were obtained for the SOX1 promoter, which is also hypomethylated during the
first 7 days of neural differentiation of NT2/D1 cells. While methylation of CpG–rich promot-
ers is considered a hallmark of silent genes, nonmethylated promoters are not necessarily asso-
ciated with active transcription [67,68]. Rather, hypomethylation allows a permissive platform
on which other mechanisms mediating the recruitment of different transcription factors act
[67]. Some of the germline- and pluripotency-associated genes with hypomethylated promot-
ers, and low expression levels in stem cells, acquire methylation during lineage commitment
[69]. Moreover, the regulatory regions of SOX2 which are unmethylated in undifferentiated
NT2/D1 cells become methylated in neurons, with no detectable SOX2 expression [23]. At the
same time, differentiation-induced repression of SOX2 is paralleled by shift from H3K4me3 to
colocalization of both H3K4me3 and H3K27me3, as demonstrated in ES cells [58].
We demonstrate that H3K4me3 on the core promoter and upstream of TSS is associated
with transcriptional induction of SOX3 gene. This finding is supported by the study by Lau-
berth et al. showing that H3K4me3 facilitates TFIID recruitment and enhances preinitiation
compex (PIC) assembly, thus promoting transcription [70]. Many promoters in ES cells are
positive for both H3K27me3 and H3K4me3 and there is evidence indicating that SOX3 and
SOX1 are among the genes with bivalent promoters. In the study by Mikkelsen et al., Sox3 was
one of the genes with bivalent promoter in mES cells, resolved into H3K4me3+ in lineage com-
mitted NP cells, while in mouse embryonic fibroblasts (MEFs) it is devoid of any histone
marks [57]. In the same study, Sox1 was found to be bivalent in both mES and NP cells, and
H3K4me3-/H3K27me3+ in MEFs [57]. Furthermore, in the study by Pan et al. SOX1 was
found to be marked by both H3K4 and H3K27 trimethylation during RA- and BMP4- induced
differentiation of ES cells [58]. This state of Sox3 and Sox1 is typical for high CpG content pro-
moters of genes with key roles in the development [57]. Further ChIP analyses are necessary in
order to test this hypothesis.
Interestingly, activation of SOX3 at day 2 was not accompanied by an increase in H2B acety-
lation. There is limited literature data regarding the contribution of H2B acetylation in regula-
tion of transcriptional regulation: a study by Kurdistani et al. demonstrated negative
correlation of H2B acetyl marks with transcription in Saccharomyces cerevisiae [71]. Analyses
of histone modification patterns in yeast suggested that acetylation of H2A and H2B has
cumulative transcriptional effects together with H3 and H4 acetylations [72,73]. The lack of
increase in H2B acetylation at the time point with the highest SOX3 expression implies that
upregulation of the SOX3 gene upon RA treatment is associated to other histone marks. Never-
theless, substantial depletion of all three H2B acetyl marks on the promoter of SOX3 at day 7
coincides with the reduced expression of SOX3 gene. These findings suggest that H2BK5ac,
H2BK16ac and H2BK120ac at the core promoter of SOX3 gene contribute to the regulation of
SOX3 gene expression, primarily at the end of the first week of neural differentiation of NT2/
D1 cells, when they interact coordinately with other deposited histone marks and transcription
apparatus or transcription factors. It would be interesting to evaluate chromatin marks on
other potential regulatory regions of SOX3 gene. For example, recent analysis has revealed that
distal enhancers of numerous genes are targeted by NF-Y, a transcriptional regulator of SOX3
gene and transcription factor with nucleosome-like properties that mediates establishment of
permissive chromatin modifications [14,74,75]. Further analysis could reveal the existence and
function of corresponding elements at distal regions of human SOX3 gene.
One of the interesting findings emerging from this study is that SOXB1 genes are differen-
tially regulated in the initial phases of neural differentiation. Based on the presented data, early
phase of neural differentiation of NT2/D1 cells could be divided into two stages. First stage
falls within the first 2 days of RA induction and is characterized by the increase in SOX3 and
reduction in SOX2 expression levels, whereas SOX1 remains unchanged. Second stage (days 4
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and 7) is accompanied by the reduction in both SOX2 and SOX3 levels, while SOX1 is upregu-
lated. In the first stage, H3K4me3 profile of the SOX2 promoter is not strongly correlated with
the decline in the expression of SOX2, as opposed to SOX3 whose upregulation at day 2 is likely
operated by H3K4me3. This is in concordance with the findings by Barrand et al. indicating
that H3K4me3 is associated with SOX2 promoter in different cell types, regardless of SOX2
expression [56]. Moreover, H2BK5ac abundance at day 2 of RA induction is considerably
lower for SOX2 than for SOX3 promoter, providing an additional proof of different states of
SOX2 and SOX3 promoters in cells undergoing differentiation. As for SOX1 promoter, we
detected raise in H3K4me3 at day 2, preceeding the actual increase in SOX1 expression levels
at day 4 and 7 of RA induction.
In the second stage, at day 7 we detected significant decrease in all analyzed histone PTMs
at promoters of SOX1, SOX2 and SOX3 genes. These implies that same epigenetic mechanisms
could contribute to the observed reduction in SOX2 and SOX3 expression levels at later stages
of neural differentiation. Conversely, detected decrease in H3K4me3 and H2B acetyl marks at
SOX1 promoter suggests that these activating histone modifications do not have considerable
role in transcriptional activation of SOX1. Therefore, other mechanisms such as a depletion of
repressive mark H3K27me3 or changes in TFs activity and signaling pathways could be attrib-
utable to changes in SOX1 expression during the neural differentiation. It would be significant
to analyze epigenetic mechanisms acting on SOXB1 genes in later stages of neural differentia-
tion, as well as in cells undergoing the process of dedifferentiation, as this could have impact
on our understanding of the exact roles of SOXB1 genes in pluripotentcy maintenance and on
improvement of guided differentiation protocols.
Regarding the other mechanisms implicated in the regulation of SOXB1 genes, we have
previously described the modulation of SOX2 and SOX3 gene expression during the early
phases of neural induction of NT2/D1 cells by RA [35]. Also, we have performed extensive
functional characterization of the regulatory regions within human SOX3 promoter involved
in RA-responsiveness [12,14,15,17]. We have described several elements, including an atypi-
cal RAR/RXRα response element (RE), located at position -259 to -154 [15], and a DR-3-like
RXR RE, positioned -68 to -54 relative to TSS [17]. We demonstrated the involvement of
several transcription factors (NF-Y, PBX1 and MEIS1) in the regulation of expression of this
gene during initial 48h of neural induction [14,15]. In addition, we analyzed whether some
aspects of transcriptional regulation are preserved between human SOX2 and SOX3 genes
during first 48h of RA induction [76]. Among many similarities (activation by Sp1, MAZ,
PBX1, MEIS1 and liganded RXR) we observed that TGIF acted as a transcriptional repressor
of the SOX3 gene, while no significant effect of this TF on the SOX2 expression has been
observed. Also, in contrast to significant impact of NF-Y on RA-induced activation of SOX3,
this TF had only mild effect on SOX2 expression in RA-induced NT2/D1 cells [76]. This
observation is in concordance with the observation of Wiebe et al. that SOX2 promoter
activity is down-regulated upon RA induction of mouse F9 EC cells [77]. Indeed, our results
confirmed speculations of Wiebe et al. that epigenetic mechanisms could contribute to the
silencing of Sox2 promoter upon differentiation of EC cells [77]. Apart from these nearby
regions expression of both genes are regulated by far distance enhancers [27,78–80] and
multiple regulatory mechanisms (e.g signaling pathways) [81–87]. It is important to empha-
size that SOX2 expression is also modulated through activity of miRNA and ncRNA.
miRNA-134 and miRNA-145 repress SOX2 expression by targeting its coding region in
mES cells and the 30-UTR in hES cells, respectively [88,89]. Also, it has been postulated that
ncRNA SOX2OT (SOX2 overlapping transcript) participate in SOX2 transcriptional regula-
tion acting as an enhancer [90]. As for the SOX1, there are several studies demonstrating the
roles of signaling pathways in SOX1 gene regulation [83,86,91,92], while data regarding TFs
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involvement in the regulation of this gene expression during the neural differentiation are
lacking.
In summary, we provide a first map of the epigenetic landscape of SOX3 in pluripotent cells
and during the early phases of neural differentiation. We found SOX3 gene to be non methyl-
ated from undifferentiated NT2/D1 to cells committed towards neural lineage. Furthermore,
we presented data regarding epigenetic mechanisms acting on SOX2 and SOX1 genes during
the initial phases of neural differentiation, pointing out to potential similarities and differences
in the epigenetic control of SOXB1 genes. These findings could contribute to the elucidation of
complex events during neural differentiation and ultimately provide better means for the
development of therapies based on the use of epigenetic-modifying drugs.
Supporting information
S1 Fig. Bioinformatic analyses of expression and histone PTMs of SOXB1 genes in
H1-ESCs and H1-derived neural progenitors. Raw data were retrieved from http://www.
roadmapepigenomics.org/ and converted in bigwig files through Galaxy tool followed by the
visualization in UCSC genome browser.
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